Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Genzyme Tissue Repair - GZTR -- Ignore unavailable to you. Want to Upgrade?

To: BostonView who wrote (333)	1/21/2000 1:46:00 PM
From: BWAC	Read Replies (1) \| Respond to of 405

<A new president, a new vision, a new marketing plan, a new focus on cost control, a new sales plan rolling out with profitability seen within a few quarters, and new products/approaches looming on the horizon.> Only thing new is the president. This has been the plab for over a year. Just not many people listening. I paid average $2. And I'm not complaining, but at $5 3/4 some risk does exist for GZTR that did not at 1 3/4. That was the only point. Why the rush to buy now? The true "plan" has not been revealed. It might just be more of the same.